"Eat less, live longer" has a firm footing in the laboratory: dietary restriction extends lifespan across species, from yeast to mammals.

A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.

Many solid tumors, including many cancers of the pancreas, breast, brain and lung, protect themselves with a dense wall of scar-like tissue.

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026.

T-Cypher Bio ("T-Cypher), a biotechnology company developing novel T cell receptor (TCR)-based T cell engagers that target high copy number antigens, today announced its relocation to Abingdon Science Park, Oxford,…

Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces Australian regulatory approval for its Yourgene® Insight DPYD…

Findings suggest omega-3 supplements improve blood pressure and inflammatory biomarkers in hypertensive patients, indicating potential therapeutic benefits.

The challenge for India’s pharmaceutical manufacturers is clear: How to reliably scale production, reduce energy costs, and safeguard operators – all at once. From November 24 to 26, 2026, L.B.…

Most psychedelic experiences don't happen in research labs. To better understand their effects, UC San Francisco scientists are going where the experiences are and launching a global study to track…

After thoracic surgery – any medical operation done inside the chest – patients can experience pain, soreness or numbness even years later.